This State Isn’t Waiting for Biden To Negotiate Drug Prices
As the federal government negotiates with drugmakers to lower the price of 10 expensive drugs for Medicare patients, impatient legislators in some states are trying to go even further. Leading the pack is Colorado, where a new Prescription Drug Affordability Review Board is set to recommend an “upper payment limit” for drugs it deems unaffordable. In late […]
Cuando tu cobertura de salud dentro de la red… simplemente se esfuma
los contratos de las aseguradoras con médicos, hospitales y farmacéuticas (o sus intermediarios, los llamados administradores de beneficios farmacéuticos) pueden cambiar abruptamente de la noche a la mañana.
How Your In-Network Health Coverage Can Vanish Before You Know It
One of the most unfair aspects of medical insurance is this: Patients can change insurance only during end-of-year enrollment periods or at the time of “qualifying life events.” But insurers’ contracts with doctors, hospitals, and pharmaceutical companies can change abruptly at any time.
The No Surprises Act Comes With Some Surprises
The No Surprises Act, the landmark law intended to protect patients from surprise out-of-network medical bills, has come with, well, some surprises. A little more than two years after it took effect, there’s good and bad news about how it’s working. First, it’s important to note that the law has successfully protected millions of patients […]
GoFundMe, ¿realmente ayuda a pagar facturas médicas?
Incluso defensores de pacientes y personal del área de ayuda financiera en hospitales recomiendan iniciar una sesión en GoFundMe como una alternativa a terminar con una cuenta en una agencia de cobros.
GoFundMe Has Become a Health Care Utility
Resorting to crowdfunding to pay medical bills has become so routine, in some cases health professionals recommend it.
The FTC Is Attacking Drugmakers’ ‘Patent Thickets’
It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.
Ouch. That ‘Free’ Annual Checkup Might Cost You. Here’s Why.
The designers of the Affordable Care Act might have assumed that they spelled out with sufficient clarity that millions of Americans would no longer have to pay for certain types of preventive care. But they didn’t reckon with America’s ever-creative medical billing juggernaut.
The FTC Escalates Biden’s Fight Against Drug Prices
It’s daggers out at the Federal Trade Commission in its fight against anticompetitive practices in health care. This past year, it has issued more stringent guidelines to block and discourage hospital mergers, and it investigated practices by middlemen in the drug supply chain. Now drug manufacturers themselves are in the agency’s crosshairs. In November, the FTC challenged the validity of more […]
From Hospital to Hospitality: Spin Doctors Brand Getting Sick as an Adventure. It’s Not.
At $1,000 a night for a private room, medical centers are offering fancy food and casting health care as a “journey.” Instead of creature comforts, how about helping us feel better?
What One Expectant Mom’s Effort To Get an RSV Shot Says About Health Policy
Today we bring you the story of a patient seeking the RSV vaccine — and how her frustrating journey illustrates why it can be so hard in the United States to get an important medicine recommended by federal regulators. Hannah Fegley of Silver Spring, Md., says she spent seven hours on the phone last month […]
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
The Shrinking Number of Primary Care Physicians Is Reaching a Tipping Point
The declining share of U.S. doctors in adult primary care is about 25% — a point beyond which many Americans won’t be able to find a family doctor at all.
Sin barreras, los precios de algunos medicamentos existentes se han disparado, incluso cuando han caído drásticamente en otros países. Los nuevos medicamentos tienen precios enormes, respaldados por el lobby y el marketing.
A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their Drugs
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
Your Exorbitant Medical Bill, Brought to You by the Latest Hospital Merger
After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country. This decreases patient choice, impedes innovation, erodes quality of care, and raises prices. And federal regulators have been slow to act.
Denials of Health Insurance Claims Are Rising — And Getting Weirder
The Department of Health and Human Services is tasked with monitoring denials both by Obamacare health plans and those offered through employers and insurers. As insurers’ denials become more common, they sometimes defy not just medical standards of care but sheer logic. Why hasn’t the agency fulfilled its assignment?
An AI Chatbot May Be Your Next Therapist. Will It Actually Help Your Mental Health?
Given a dire shortage of human behavioral health providers in the U.S., it may prove tempting for insurers to offer up apps and chatbots to meet the federal mental health parity requirement. But artificial intelligence, by definition fake, can’t master the empathic flow between patient and doctor that’s central to therapy.
Guns Are the Biggest Public Health Threat Kids Face. Why Aren’t They Getting the Message?
Today’s public service announcements on gun safety feel somewhat sanitized. It’s time to act with the same kind of visceral public campaign that helped de-glorify smoking. Would filmmakers commit to making action movies without guns, just as filmmakers stopped making smoking glamorous in films?
Did the US Jump the Gun With the New Omicron-Targeted Vaccines?
With fears of a winter surge looming, government agencies have authorized and encouraged vaccination with a newly formulated booster. But the science to support that decision remains inconclusive.
